Using GM-CSF as a Host Directed Therapeutic Against COVID-19
Clinical trial NCT04400929 · COMPLETED
Trial details
- NCT number
- NCT04400929
- Sponsor
- Singapore General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2022-01-26
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.